EP #315 Brad Dieter: AI, Ozempic, and The Industry Bull Whip

Brad Dieter, co-owner and CEO of Macros Inc. and a leading voice in fitness coaching, shares his insights on the future of the industry. He discusses the impact of AI, emphasizing the need for ethical considerations in its use. Brad also navigates the complexities surrounding Ozempic and similar GLP-1 drugs, highlighting their role in weight management and muscle preservation. Additionally, he underscores the significance of professional networking and community engagement for career growth, while introducing exciting plans for an upcoming conference.